Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Cocaine use increases [3H]WIN 35428 binding sites in human striatum.

Little KY, Kirkman JA, Carroll FI, Clark TB, Duncan GE.

Brain Res. 1993 Nov 19;628(1-2):17-25.

PMID:
8313144
2.

Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.

Letchworth SR, Nader MA, Smith HR, Friedman DP, Porrino LJ.

J Neurosci. 2001 Apr 15;21(8):2799-807.

3.

Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration.

Wilson JM, Nobrega JN, Carroll ME, Niznik HB, Shannak K, Lac ST, Pristupa ZB, Dixon LM, Kish SJ.

J Neurosci. 1994 May;14(5 Pt 2):2966-79.

4.

Striatal dopaminergic abnormalities in human cocaine users.

Little KY, Zhang L, Desmond T, Frey KA, Dalack GW, Cassin BJ.

Am J Psychiatry. 1999 Feb;156(2):238-45.

PMID:
9989560
5.

Dopamine transport function is elevated in cocaine users.

Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S.

J Neurochem. 2002 Apr;81(2):292-300.

6.

Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study.

Little KY, McLaughlin DP, Zhang L, McFinton PR, Dalack GW, Cook EH Jr, Cassin BJ, Watson SJ.

Arch Gen Psychiatry. 1998 Sep;55(9):793-9.

PMID:
9736005
7.

Cocaine induction of dopamine transporter trafficking to the plasma membrane.

Little KY, Elmer LW, Zhong H, Scheys JO, Zhang L.

Mol Pharmacol. 2002 Feb;61(2):436-45.

9.
10.

[125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain.

Little KY, Kirkman JA, Carroll FI, Breese GR, Duncan GE.

J Neurochem. 1993 Dec;61(6):1996-2006.

PMID:
8245956
11.

Striatal quinolinic acid lesions increase [3H]WIN 35,428 binding to the dopamine transporter.

Gehlert DR, Schoepp DD.

Neurochem Int. 1992 Dec;21(4):581-4.

PMID:
1303740
12.

High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims.

Staley JK, Hearn WL, Ruttenber AJ, Wetli CV, Mash DC.

J Pharmacol Exp Ther. 1994 Dec;271(3):1678-85.

PMID:
7996484
13.

Striatal [125I]RTI-55 binding sites in cocaine-abusing humans.

Little KY, Carroll FI, Butts JD.

Prog Neuropsychopharmacol Biol Psychiatry. 1998 Apr;22(3):455-66.

PMID:
9612843
14.

Dopamine transporter development in postnatal rat striatum: an autoradiographic study with [3H]WIN 35,428.

Coulter CL, Happe HK, Murrin LC.

Brain Res Dev Brain Res. 1997 Dec 19;104(1-2):55-62.

PMID:
9466707
15.

Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration.

Letchworth SR, Sexton T, Childers SR, Vrana KE, Vaughan RA, Davies HM, Porrino LJ.

J Neurochem. 1999 Nov;73(5):1982-9.

16.
17.

[3H]WIN 35,428 binding in the caudate nucleus of the rabbit: evidence for a single site on the dopamine transporter.

Aloyo VJ, Ruffin JS, Pazdalski PS, Kirifides AL, Harvey JA.

J Pharmacol Exp Ther. 1995 Apr;273(1):435-44.

PMID:
7714799
18.

Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.

Scheffel U, Steinert C, Kim SE, Ehlers MD, Boja JW, Kuhar MJ.

Synapse. 1996 Jun;23(2):61-9.

PMID:
8723710
20.

Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.

Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, Adams VI, Smialek J, Anderson WR, Shannak K, Deck J, Niznik HB, Kish SJ.

Ann Neurol. 1996 Sep;40(3):428-39.

PMID:
8797532

Supplemental Content

Support Center